MedTrace Logo

Pharmacogenomics to Improve Supportive Care Symptoms.

NCT06856122 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-07-14

No results posted yet for this study

Summary

To understand the clinical utility of multi-gene pharmacogenetic testing in patients receiving palliative and supportive care across palliative care settings (inpatient hospital, outpatient), specifically to calculate a drug-gene interaction ratio, based on extant prescriptions paired with an individual's pharmacogenetic results.

Conditions

  • Palliative Care
  • Supportive Care

Sponsors & Collaborators

  • Manchester Centre for Genomic Medicine - St. Mary's Hospital University of Manchester

    collaborator UNKNOWN

  • Norfolk and Norwich University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dr Martyn Patel · Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

  • Dr Caroline Barry · Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-09
Primary Completion
2026-04-01
Completion
2026-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06856122 on ClinicalTrials.gov